Medi Assist Healthcare Clarifies Timeline for INR 198 Crore Preferential Issue Proceeds Utilization
Medi Assist Healthcare plans to raise INR 198 crore through a preferential issue of 37,01,000 equity shares to MIT and 238 Plan Associates LLC. INR 150 crore will be used for debt repayment via a subsidiary, while INR 48 crore is allocated for general corporate purposes. The company expects to utilize the funds within two years of share allotment. The preferential issue will slightly decrease promoter holding from 20.37% to 19.36%, while increasing public shareholding from 78.73% to 79.79%. Foreign Portfolio Investors' stake is expected to rise from 13.76% to 16.94%.

*this image is generated using AI for illustrative purposes only.
Medi Assist Healthcare has provided clarifications regarding the timeline for utilizing proceeds from a recent preferential issue of equity shares. The company plans to raise INR 198.00 crore through the issuance of 37,01,000 equity shares to Massachusetts Institute of Technology (MIT) and 238 Plan Associates LLC.
Proceeds Utilization Plan
The company has outlined its plans for the utilization of the funds raised:
- Debt Repayment: INR 150.00 crore will be invested in a subsidiary for debt prepayment or repayment.
- General Corporate Purposes: The remaining INR 48.00 crore will be used for general corporate purposes.
Medi Assist Healthcare has clarified that the utilization of these funds will commence on the date of allotment of shares pursuant to the preferential issue. The company expects to complete the utilization of the entire amount within two years from the commencement date.
Shareholder Approval and Regulatory Compliance
The preferential issue was approved by shareholders in an extraordinary general meeting. The clarification comes in response to observations made by the National Stock Exchange of India Limited, demonstrating the company's commitment to regulatory compliance and transparency.
Impact on Shareholding Pattern
Medi Assist Healthcare has also provided an updated shareholding pattern on a fully diluted basis, considering the impact of the preferential issue:
Category | Pre-Issue (%) | Post-Issue (%) |
---|---|---|
Promoter Group | 20.37 | 19.36 |
Non-Promoter (Public) | 78.73 | 79.79 |
- Institutions | 55.66 | 57.85 |
- Non-Institutions | 23.08 | 21.93 |
The updated pattern shows a slight decrease in promoter group holding from 20.37% to 19.36%, while the non-promoter public shareholding increases from 78.73% to 79.79% post the preferential issue.
Institutional Interest
Notably, the preferential issue has attracted significant institutional interest. Foreign Portfolio Investors' (Category I and II) stake is expected to increase from 13.76% to 16.94% following the issue, indicating growing confidence in Medi Assist Healthcare's business prospects.
This move by Medi Assist Healthcare to raise funds through a preferential issue and provide detailed clarifications on its utilization demonstrates the company's proactive approach to capital management and commitment to keeping investors informed. As the company moves forward with its plans, stakeholders will be keenly watching how effectively these funds are deployed to strengthen Medi Assist Healthcare's financial position and support its growth initiatives.
Historical Stock Returns for Medi Assist Healthcare
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-0.53% | +0.40% | -0.81% | +17.44% | -18.93% | +12.83% |